CP

Chakaravarthy Pilla Malathi Asokan

Director Director DIN 02131651
DIN 02131651 First appointment May 2008 Primary industry Trading
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since May 2008
Shareholding value β€’β€’β€’β€’ Premium profile

About Chakaravarthy Pilla Malathi Asokan

Data last updated:

Chakaravarthy Pilla Malathi Asokan was a Director at Lister & Berg Biopharma & Chemicals Private Limited (2009–2021) and Director at Tri Inpharmex Services Private Limited (from 2008). The companies operate in Trading.

DIN 02131651
Primary Designation Director
Industry Trading
First Appointment 21 May 2008
Oldest Company Age 18 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director23 Sep 20092009₹20,800 (FY 2026)Active
Director21 May 20082008Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Tri Inpharmex Services Private Limited
Lister & Berg Biopharma & Chemicals Private Limited
Premium access

Shareholding and investment profile for Chakaravarthy Pilla Malathi Asokan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chakaravarthy Pilla Malathi Asokan

Chakaravarthy Pilla Malathi Asokan was first appointed on 21 May 2008 as Director at Tri Inpharmex Services Private Limited. The most recent appointment on record is 23 Sep 2009 at Lister & Berg Biopharma & Chemicals Private Limited.

Chakaravarthy Pilla Malathi Asokan held 2 earlier board appointments: Lister & Berg Biopharma & Chemicals Private Limited (Director, 23 Sep 2009 to 26 Jun 2021); Tri Inpharmex Services Private Limited (Director, from 21 May 2008).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available